| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/20/2003 | WO2003014101A1 Hydroxamic acid derivatives |
| 02/20/2003 | WO2003014098A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
| 02/20/2003 | WO2003014073A1 Fatty acid compounds, preparation and uses thereof |
| 02/20/2003 | WO2003013614A1 Collagen-containing oral preparations, drugs and quasi drugs |
| 02/20/2003 | WO2003013612A1 Polysaccharide-containing compositions and use thereof |
| 02/20/2003 | WO2003013595A1 Compounds and methods for the modulation of immune responses |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013575A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 02/20/2003 | WO2003013569A2 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 02/20/2003 | WO2003013561A1 Oral compositions for the treatment of scalp disorders |
| 02/20/2003 | WO2003013557A1 Use of fly larvae extracts for the treatment of wounds |
| 02/20/2003 | WO2003013548A1 Medical composition for external use for dermatosis |
| 02/20/2003 | WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists |
| 02/20/2003 | WO2003013529A1 Paroxetine glycyrrhizinate |
| 02/20/2003 | WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | WO2003013517A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/20/2003 | WO2003013513A1 Stable emulsion composition |
| 02/20/2003 | WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands |
| 02/20/2003 | WO2003013496A1 Reduction of hair growth |
| 02/20/2003 | WO2003013493A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 02/20/2003 | WO2003013489A1 Treatment of nail infections with no |
| 02/20/2003 | WO2003013487A2 Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
| 02/20/2003 | WO2003013461A2 Cosmetic composition and method of treating skin |
| 02/20/2003 | WO2003013458A1 Cosmetic and/or pharmaceutical preparations containing plant extracts |
| 02/20/2003 | WO2003013455A2 Cosmetic and dermatological light protective formulations containing benzotriazole derivatives and latex particles |
| 02/20/2003 | WO2003013449A2 Method of reducing hair growth by applying alpha-difluoromethylornithine |
| 02/20/2003 | WO2003013445A1 Nanocapsules containing a steroid for cosmetic compositions |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2003013432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 02/20/2003 | WO2003013427A2 A method for preparing fluticasone derivatives |
| 02/20/2003 | WO2003006001A8 ss-ADRENERGIC BLOCKADE REVERSAL OF CATABOLISM AFTER SEVERE BURN |
| 02/20/2003 | WO2002096927A3 Ribozyme based treatment of female reproductive diseases |
| 02/20/2003 | WO2002083733A3 Polynucleotides and polypeptides of the ifnalpha-6 gene |
| 02/20/2003 | WO2002074742A3 Cdk-inhibitory indirubin derivatives having an increased solubility |
| 02/20/2003 | WO2002072585A3 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/20/2003 | WO2002070525A3 Nitrogen-based camptothecin derivatives |
| 02/20/2003 | WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 02/20/2003 | WO2002064126A3 Method of treating of demyelinating diseases or conditions |
| 02/20/2003 | WO2002054933A3 Method for photodynamic therapy and applicator for carrying out said therapy |
| 02/20/2003 | WO2002053170A3 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo |
| 02/20/2003 | WO2002051427A8 Improved and stable extract from hypericum perforatum l., method for the production thereof and its use as a topical medicament |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002047730A8 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 02/20/2003 | WO2002043731A3 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 02/20/2003 | WO2002029088A9 Highly expressible genes |
| 02/20/2003 | WO2002028420A9 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 02/20/2003 | WO2002022621B1 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 02/20/2003 | WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells |
| 02/20/2003 | WO2001022952A3 Use of tace inhibitors |
| 02/20/2003 | US20030036568 Permeation enhancers |
| 02/20/2003 | US20030036561 Topical composition includes alpha -difluoromethylornithine and a dermatologically acceptable vehicle including urea. |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036536 Substituted benzylthioacetic acids and esters |
| 02/20/2003 | US20030036511 Preparation of pure isoforms using TSK sulfopropyl cation exchange chromatography and reverse phase high performance liquid chromatography. |
| 02/20/2003 | US20030036502 Methods for enhancing wound healing |
| 02/20/2003 | US20030036174 Hair follicle growth factor proteins |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | US20030035819 Skin care composition that mediates cell to cell communication |
| 02/20/2003 | US20030035799 Glycosylated antibody |
| 02/20/2003 | US20030035787 Polyanhydrides with biologically active degradation products |
| 02/20/2003 | CA2701551A1 Polysaccharide-containing compositions and use thereof |
| 02/20/2003 | CA2457400A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 02/20/2003 | CA2456935A1 Cosmetic composition and method of treating skin |
| 02/20/2003 | CA2456833A1 Polysaccharide-containing compositions and use thereof |
| 02/20/2003 | CA2456814A1 Use of fly larvae extracts for the treatment of wounds |
| 02/20/2003 | CA2456533A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 02/20/2003 | CA2456328A1 Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof |
| 02/20/2003 | CA2456291A1 Hydroxamic acid derivatives |
| 02/20/2003 | CA2456288A1 Fatty acid compounds, preparation and uses thereof |
| 02/20/2003 | CA2456175A1 Benzoquinone ansamycins |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | CA2456124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | CA2455756A1 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 02/20/2003 | CA2455631A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/20/2003 | CA2454684A1 Eukaryotic cells and method for preserving cells |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453433A1 Methods of use for novel sulfur containing organic nitrate compounds |
| 02/19/2003 | EP1284266A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 02/19/2003 | EP1284134A2 External skin preparations for suppressing sebum secretion |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283828A1 Novel polymorph v of torasemide |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283823A1 Novel mmp-2/mmp-9 inhibitors |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1283713A2 Combined cartilage and plant extract compositions |
| 02/19/2003 | EP1283708A2 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 02/19/2003 | EP1283672A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin" |
| 02/19/2003 | EP0950065B1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
| 02/19/2003 | EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |